One US-made drug treats congenital syphilis, and the country is running short

The United States has a shortage of the only first-line medication recommended for pregnant women with syphilis to prevent passing it to their baby, even as congenital syphilis rates have been skyrocketing. The U.S. Food and Drug Administration says supplies won’t return to normal until December 2027.